Cipta Sarana Medika Tbk. vs Pelat Timah Nusantara Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Pelat Timah Nusantara Tbk. trades at Rp190 (market cap 461.77B, 6.64M 24h volume). The key difference: Pelat Timah Nusantara Tbk. is far larger — about 2.9× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 6.64M). Which is the better fit depends on your goals.
| DKHH | NIKL | |
|---|---|---|
Market Cap | 158.12B | 461.77B |
Volume | 8.21M | 6.64M |
Lot | 82.15K | 66.43K |
Turnover | 515.2M | 1.26B |
Average Price | 62.72 | 189.28 |
Value | 515.2M | 1.26B |
Indicative Equilibrium Price | 63 | 190 |
Indicative Equilibrium Volume | 1.33K | 939 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Pelat Timah Nusantara Tbk (PT Latinusa) was the first company in Indonesia that produces high-quality tinplate with international standards. PT Latinusa was founded on August 19, 1982 under the Company Act No.45, drawn up before Imas Fatimah, SH, and the current majority shareholder is the Japanese consortium consisting of Nippon Steel Corporation, Mitsui Co.. Ltd.., Nippon Steel Trading Co.., And Metal One. Nippon Steel Corporation is also the provider of our main raw material, Tin Mill Black Plate (TMBP), so the availability of raw materials is always guaranteed.
Read more on NIKL →